An observational study in Apparently Healthy People Aged 55 and Over, sponsored by Jung-Ha Kim. Completed. Open to participants aged 55 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-05-12.
Sponsored by Jung-Ha Kim · Observational
Quality of life (QoL) is an important factor for successful aging. Telomere length is an indicator of cellular aging and cumulative biological stress and is thus related to health status and survival. However, the relationship between QoL and telomere length has not yet been examined. In this study we investigated the relationship between leukocyte telomere length (LTL) and QoL.
However, the relationship between overall QoL and LTL has not previously been investigated. Therefore, this study was conducted to examine the relationship between LTL and QoL. QoL was measured by the Korean version of the 36-item short-form health survey (SF-36), which is a multidimensional scale consisting of subjective evaluation.
This is the only study on the registry with Jung-Ha Kim as lead sponsor.
Counted across the registry records on this site, refreshed daily.
A total of 164 apparently healthy subjects (82 couples) aged 55 and over were included in this study.
Exclusion Criteria:
Quality of life which was measured by the Korean version of the 36-item short-form health survey (SF-36)
leukocyte telomere length
Leukocyte telomere length was measured as telomere repeat copy number relative to single gene copy number by quantitative real-time PCR
Time frame: 8months
No study locations are listed for this record.
This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.